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It has been three years since the publication of the first
article in the Journal of Carcinogenesis; it was the editorial
that espoused the need for the launch of the journal. Hav-
ing seen three springs and three falls, it is time to ask
where we are as a journal and where we want to be in the
years to come.
The past three years have been satisfying publishing years
for JC, given the fact that it is an online publication with
processing charges paid by the authors under the open
access model and there has been stiff competition from
the established print journals. The quality of manuscripts
published in JC is very impressive and I am confident that
it will only improve as the journal grows. Scientists seem
to be conditioned to measure the quality of a journal and
the articles it publishes in terms of 'impact factor'. I am
glad that JC has made a significant impact on the carcino-
genesis research community and I am sure that an impact
factor for the journal will follow soon.
As we enter our fourth year, we have a reason to be upbeat.
We have been fortunate in attracting several international
scientists, both from industry and academia, to the Edito-
rial Board. I am especially pleased that Dr. Rishab Gupta,
director of immunodiagnosis and Vice-president for Edu-
cation at John Wayne Cancer Institute, joined the editorial
board as a managing editor. He brings outstanding lead-
ership and vision to the editorial board. I am also pleased
to announce that Carcinogenesis Foundation http://
www.carcifoundation.org was recently founded with New
Jersey, USA, as a home base.
The formation of the Carcinogenesis Foundation is a his-
toric opportunity. While its goal is to promote and
advance research in the field of carcinogenesis, it has a
specialized mission of understanding the phenomenon of
increased cancer incidence among individuals who
migrate to the western countries. The phenomenon is con-
ceptualized and can be called Acquired Risk for Cancer
Incidence, ARCI. A manuscript being published in the
Journal of Carcinogenesis in November 2005 presents an
interesting work that supports the concept of ARCI. (Can-
cer Incidence in the South Asian population of California,
1988–2000 Ratnali V Jain, Paul K Mills and Arti Parikh-
Patel). Investigations into new paradigms like ARCI will
have a far-reaching impact on the field of carcinogenesis
and will open up new horizons for the scientific endeav-
ors that seek to unravel the molecular secrets of malignant
transformation of a normal cell. Several interesting ques-
tions are currently being addressed in the field of carcino-
genesis research and they are expected to lead to insightful
answers. Carcinogenesis Foundation and the Journal of
Carcinogenesis will have tremendous opportunity to con-
tribute to understanding the carcinogenesis processes and
thereby to chemoprevention efforts.
While research is underway in several laboratories around
the world, the public is waiting with a hope; a hope that a
clear message that they could trust would emerge as to
which factors increase the risk of carcinogenesis and
which do not as the enlightened scientific community
may have already deliberated and researched on them.
How difficult is it to answer if vitamin E and B are protec-
tive against carcinogenesis or if they promote carcinogen-
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esis? How difficult is it to find out if aspirin or other non-
steroidal anti-inflammatory drugs prevent cancers? It may
not be difficult if proper scientific methods and
approaches are employed and the outcome is not preju-
diced one way or the other for any reasons. It may not be
difficult if socially conscious scientists approach the ques-
tions collectively with a humane outlook. As scientific
approach is expected to yield one answer to one question
and that answer should be verifiable in any part of the
world, where is the source of discordant results to ques-
tions like those mentioned above? There seems to be two
sources, one is study design and the investigators and the
other is inherent in the biology of human subjects and
experimental systems used for the study.
The biotechnology industry analysts seem to think that
next decade will be dominated by products and processes
that address the 'personalized medicine'. It certainly is the
ultimate alternative to the current 'one pill cures all'
approach. However, it is inevitable to go through commu-
nity-based medicine before customized medicine can
become a reality. Acquired Risk for Cancer Incidence is
a concept that entails us to the community based carcino-
genesis and cancer prevention research. Carcinogenesis
Foundation proposes to participate in and encourage
efforts that attempt to understand how the inherent bio-
logical and genetic variations in individuals influence the
outcome of cancer prevention trials or cancer treatment.
While discordant results in biomedical research may have
genesis in genetic diversities of subjects, a distinct contri-
bution for this comes from lack of uniform protocols and
procedures and lack of policies to prevent irresponsible
scientific practices. Unfortunately, there are no interna-
tional mechanisms to impose sanctions on ill trained sci-
entists whose results misguide the public as well as the
fellow scientists. It is interesting that scientific profession
is the only profession that does not have certification and
professional regulations like medical profession and oth-
ers. It is time to think of ways and means by which a uni-
fied approach and common protocols are employed in
biomedical research. It is also imperative that the individ-
uals who go to the bench are screened and certified for
technical competence and scientific integrity. These con-
siderations may call for the creation of a body of a 'jury
scientists'. Should cancer researchers be the in the fore-
front of such an experiment?